Skip to main content

Table 4 Comparision of the status of lipidemia between breast cancer patients with pre and post chemotherapy

From: Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy

Parameter

Pre-chemotherapy group(n = 394)

Post-chemotherapy group (n = 394)

Mean ± SD (mmol/L)

Abnormal (n, %)

Mean ± SD (mmol/L)

Abnormal (n, %)

TC

4.47 ± 0.91**

79(20.05)**

4.80 ± 0.88

119(30.20)

TG

1.31 ± 1.20**

72(18.27)**

1.77 ± 1.21

160(40.61)

HDL-C

1.43 ± 0.36**

20(5.08)*

1.28 ± 0.35

42(10.66)

LDL-C

2.78 ± 0.80**

135(34.26)**

3.15 ± 0.81

203(51.52)

Apo-A1

1.48 ± 0.25**

10(2.54)**

1.39 ± 0.24

35(8.88)

Apo-B

0.85 ± 0.23**

11(2.79)

0.97 ± 0.24

20(5.08)

Dyslipidemia

201(45.07) **

306(68.61)

  1. *p < 0.05 **p < 0.001 comparision of the status of lipidemia between pre and post chemotherapy among breast cancer patients; TC: total-cholesterol, TG: triglyceride, HDL-C: high density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol, Apo-A1: apolipoprotein-A1, Apo-B: apolipoprotein-B